- Home
- NYMTL vs IMNM Comparison
NYMTL vs IMNM Comparison
Compare NYMTL & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTL
- IMNM
- Stock Information
- Founded
- NYMTL N/A
- IMNM 2006
- Country
- NYMTL United States
- IMNM United States
- Employees
- NYMTL 79
- IMNM N/A
- Industry
- NYMTL Real Estate Investment Trusts
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- NYMTL Real Estate
- IMNM Health Care
- Exchange
- NYMTL Nasdaq
- IMNM Nasdaq
- Market Cap
- NYMTL N/A
- IMNM 747.7M
- IPO Year
- NYMTL N/A
- IMNM 2020
- Fundamental
- Price
- NYMTL $21.26
- IMNM $11.89
- Analyst Decision
- NYMTL
- IMNM Strong Buy
- Analyst Count
- NYMTL 0
- IMNM 4
- Target Price
- NYMTL N/A
- IMNM $28.75
- AVG Volume (30 Days)
- NYMTL N/A
- IMNM 873.3K
- Earning Date
- NYMTL N/A
- IMNM 11-07-2024
- Dividend Yield
- NYMTL N/A
- IMNM N/A
- EPS Growth
- NYMTL N/A
- IMNM N/A
- EPS
- NYMTL N/A
- IMNM N/A
- Revenue
- NYMTL N/A
- IMNM $10,784,000.00
- Revenue This Year
- NYMTL N/A
- IMNM N/A
- Revenue Next Year
- NYMTL N/A
- IMNM N/A
- P/E Ratio
- NYMTL N/A
- IMNM N/A
- Revenue Growth
- NYMTL N/A
- IMNM 62.73
- 52 Week Low
- NYMTL N/A
- IMNM $6.93
- 52 Week High
- NYMTL N/A
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- NYMTL 53.20
- IMNM 33.67
- Support Level
- NYMTL $21.20
- IMNM $11.92
- Resistance Level
- NYMTL $22.28
- IMNM $13.40
- Average True Range (ATR)
- NYMTL 0.26
- IMNM 0.80
- MACD
- NYMTL -0.06
- IMNM -0.26
- Stochastic Oscillator
- NYMTL 29.92
- IMNM 3.16
About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.